Birdwatch Note
2024-09-27 07:56:52 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
実際にはHPVワクチンはランダム化比較試験のメタアナリシスで、そのHPV感染と子宮頸部上皮内腫瘍を予防する高い有効性が示されています。 https://www.tandfonline.com/doi/full/10.1080/14760584.2023.2287135 また、近年の観察研究により下記の「子宮頸がん罹患に対する予防効果」の項目にあるように特に若年時に接種した時に高い子宮頸がん予防効果を示す事も既に明らかになっています。 https://www.ncc.go.jp/html/icc/hpvcancer/index.html 例えばスウェーデンの4価ワクチンの研究は交絡因子補正後にワクチン接種時の年齢別にみた相対リスクは、17歳未満で接種した場合は未接種の0.12倍に、デンマークの研究でも同じく16歳未満で接種した場合に未接種の0.14倍になっています。
Written by F4D2E4CA66E08B99BDDE8328BBF4C2313B853B3595C8AC38600E463328C72D9D
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1839552238584496485
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1839574918423572553
- noteId - 1839574918423572553
- participantId -
- noteAuthorParticipantId - F4D2E4CA66E08B99BDDE8328BBF4C2313B853B3595C8AC38600E463328C72D9D Participant Details
- createdAtMillis - 1727423812858
- tweetId - 1839552238584496485
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 1
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- 実際にはHPVワクチンはランダム化比較試験のメタアナリシスで、そのHPV感染と子宮頸部上皮内腫瘍を予防する高い有効性が示されています。 https://www.tandfonline.com/doi/full/10.1080/14760584.2023.2287135 また、近年の観察研究により下記の「子宮頸がん罹患に対する予防効果」の項目にあるように特に若年時に接種した時に高い子宮頸がん予防効果を示す事も既に明らかになっています。 https://www.ncc.go.jp/html/icc/hpvcancer/index.html 例えばスウェーデンの4価ワクチンの研究は交絡因子補正後にワクチン接種時の年齢別にみた相対リスクは、17歳未満で接種した場合は未接種の0.12倍に、デンマークの研究でも同じく16歳未満で接種した場合に未接種の0.14倍になっています。
Note Ratings
rated at | rated by | |
2024-09-30 00:34:57 -0500 | Rating Details | |
2024-09-28 22:13:04 -0500 | Rating Details | |
2024-09-28 10:18:03 -0500 | Rating Details | |
2024-09-28 07:45:25 -0500 | Rating Details | |
2024-09-28 03:21:00 -0500 | Rating Details | |
2024-09-28 01:56:04 -0500 | Rating Details | |
2024-09-28 01:38:49 -0500 | Rating Details | |
2024-09-28 00:50:59 -0500 | Rating Details | |
2024-09-27 21:31:35 -0500 | Rating Details | |
2024-09-27 17:15:13 -0500 | Rating Details | |
2024-09-27 16:48:38 -0500 | Rating Details | |
2024-09-27 16:41:48 -0500 | Rating Details | |
2024-09-27 16:09:33 -0500 | Rating Details | |
2024-09-27 16:08:54 -0500 | Rating Details | |
2024-09-27 15:35:13 -0500 | Rating Details | |
2024-09-27 15:09:59 -0500 | Rating Details | |
2024-09-27 14:45:16 -0500 | Rating Details | |
2024-09-27 14:37:03 -0500 | Rating Details | |
2024-09-27 12:29:38 -0500 | Rating Details | |
2024-09-27 12:08:39 -0500 | Rating Details | |
2024-09-27 12:01:06 -0500 | Rating Details | |
2024-09-27 11:48:27 -0500 | Rating Details | |
2024-09-27 11:47:58 -0500 | Rating Details | |
2024-09-27 11:44:20 -0500 | Rating Details | |
2024-09-27 11:32:31 -0500 | Rating Details | |
2024-09-27 11:23:06 -0500 | Rating Details | |
2024-09-27 11:21:07 -0500 | Rating Details | |
2024-09-27 11:17:12 -0500 | Rating Details | |
2024-09-27 11:16:37 -0500 | Rating Details | |
2024-09-27 11:15:49 -0500 | Rating Details | |
2024-09-27 11:15:23 -0500 | Rating Details | |
2024-09-27 11:12:11 -0500 | Rating Details | |
2024-09-27 11:07:13 -0500 | Rating Details | |
2024-09-27 11:04:49 -0500 | Rating Details | |
2024-09-27 11:02:34 -0500 | Rating Details | |
2024-09-27 11:02:22 -0500 | Rating Details | |
2024-09-27 11:02:12 -0500 | Rating Details | |
2024-09-27 08:28:46 -0500 | Rating Details | |
2024-09-27 07:22:46 -0500 | Rating Details | |
2024-09-27 06:37:38 -0500 | Rating Details | |
2024-09-27 06:21:44 -0500 | Rating Details | |
2024-09-27 05:00:14 -0500 | Rating Details | |
2024-09-27 04:48:45 -0500 | Rating Details | |
2024-09-27 04:38:04 -0500 | Rating Details | |
2024-09-27 04:36:27 -0500 | Rating Details | |
2024-09-27 04:32:13 -0500 | Rating Details | |
2024-09-27 04:30:50 -0500 | Rating Details | |
2024-09-27 04:24:18 -0500 | Rating Details | |
2024-09-27 04:20:20 -0500 | Rating Details | |
2024-09-27 04:19:51 -0500 | Rating Details | |
2024-09-27 04:04:51 -0500 | Rating Details | |
2024-09-27 03:55:58 -0500 | Rating Details | |
2024-09-27 03:49:02 -0500 | Rating Details | |
2024-09-27 03:48:37 -0500 | Rating Details | |
2024-09-27 03:48:28 -0500 | Rating Details | |
2024-09-27 03:46:56 -0500 | Rating Details | |
2024-09-27 03:40:41 -0500 | Rating Details | |
2024-09-27 03:38:59 -0500 | Rating Details | |
2024-09-27 03:37:47 -0500 | Rating Details | |
2024-09-27 03:32:33 -0500 | Rating Details | |
2024-09-27 03:32:09 -0500 | Rating Details | |
2024-09-27 03:32:06 -0500 | Rating Details | |
2024-09-27 03:30:59 -0500 | Rating Details | |
2024-09-27 03:25:48 -0500 | Rating Details | |
2024-09-27 03:22:56 -0500 | Rating Details | |
2024-09-27 03:13:41 -0500 | Rating Details | |
2024-09-27 03:12:05 -0500 | Rating Details | |
2024-09-27 03:07:04 -0500 | Rating Details | |
2024-10-01 19:40:58 -0500 | Rating Details | |
2024-09-27 11:10:07 -0500 | Rating Details | |
2024-09-27 10:46:11 -0500 | Rating Details | |
2024-09-27 03:51:21 -0500 | Rating Details | |
2024-09-27 03:31:36 -0500 | Rating Details | |
2024-09-27 03:29:34 -0500 | Rating Details | |
2024-09-27 03:24:53 -0500 | Rating Details |